CSOP Hang Seng Biotech ETF (03174.HK) Fell 2.24% to 3.310
Newtimespace News, as of 15:04 on May 15, CSOP Hang Seng Biotech ETF (03174.HK) was quoted at HKD 3.310, down 2.24%. The ETF opened at HKD 3.398, with a high of HKD 3.398 and a low of HKD 3.286. The latest Net Asset Value (NAV) per unit is HKD 3.394, with a premium rate of -0.22%. The asset size is approximately HKD 862 million.
CSOP Hang Seng Biotech ETF (03174.HK) tracks the Hang Seng Biotech Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to reflect the overall performance of biotechnology companies listed in Hong Kong, covering companies in sectors such as pharmaceuticals, biotechnology, and healthcare equipment. It serves as one of the important market benchmarks reflecting the performance of Hong Kong's biotech sector.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- TIGERMED(03347.HK) will spend CNY 175.37 million to repurchase 4.44 million shares on Jun 12, 2026
- HAIER SMARTHOME(06690.HK) will spend CNY 32.86 million to repurchase 1.55 million shares on Jun 12, 2026
- TAT HONG EQUIP(02153.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of CNY 120.63 million, loss widened by 0.06% YoY
- BAY AREA DEV (00737.HK) plans to issue in total 250 million shares by subscription, with estimated net proceeds of HKD 456 million
- VC HOLDINGS (00821.HK) plans to issue up to 65.86 million shares by placement, with estimated net proceeds of HKD 14 million